Starting doses are intentionally low to minimise side effects and are gradually increased based on your response
Some patients respond very well, while others experience side effects, cost barriers, medication shortages, insurance denials, or weight regain after stopping therapy
Although sulfonylureas are associated with slightly greater upfront reductions in glycosylated hemoglobin levels (HbA1c, 1% to 1.25% reduction) relative to metformin (0.5% to 1.25%) (23) in the UKPDS study, after 6 months, reduction in a1c levels were similar between groups on either therapy
Never discontinue GLP-1 medication without medical guidance, as abrupt cessation may worsen glycaemic control or cause weight regain
Administering Your Semaglutide Injection Now that youre prepared, lets dive into the actual injection process
For private-label formulation needs, Guangzhou Xiaoshi Biotechnology and Wansongtang Health Group offer balanced MOQs and pricing